http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#Head http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#assertion http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#provenance http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#pubinfo http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#assertion http://purl.obolibrary.org/obo/DOID_13550 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_13550 http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01062 http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association http://www.w3.org/2000/01/rdf-schema#label "Oxybutynin chloride is contraindicated in patients with untreated angle closure glaucoma and in patients with untreated narrow anterior chamber angles since anticholinergic drugs may aggravate these conditions. It is also contraindicated in partial or complete obstruction of the gastrointestinal tract, paralytic ileus, intestinal atony of the elderly or debilitated patient, megacolon, toxic megacolon complicating ulcerative colitis, severe colitis, and myasthenia gravis. It is contraindicated in patients with obstructive uropathy and in patients with unstable cardiovascular status in acute hemorrhage. Oxybutynin chloride is contraindicated in patients who have demonstrated hypersensitivity to the product." http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB01062 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#provenance http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#pubinfo http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#sig http://purl.org/nanopub/x/hasSignature gpm2zGnIO8q1dO0nVjSJjfF9taZtt48742X+5ebej+ZCi5+mIFDS5oxvgtJ2+BEwejJB20rel5TwWkt9njsCff11JeEfvNfrCVDqErMRL/p631qRcfpiack9tIGTAqXeqfec1DyeOtqOENEPDh9BCfx5wA2mfhRlSl/0eAQvD8A= http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg http://purl.org/dc/terms/created 2021-08-25T13:47:02.040+02:00 http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAYegrimkW9GMbtCNeQugrJoGTD65RhTfiFGmsetU_UUg https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY